Laddar...
A Phase III Study of IncobotulinumtoxinA in the Treatment of Glabellar Frown Lines
Objective: To investigate the efficacy and safety of incobotulinumtoxinA (also known as botulinum toxin type A [150 kDa], free from complexing proteins, or previously as NT 201), for the treatment of glabellar frown lines, in a prospective, open-label, multicenter, Phase III trial. Design: The study...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Matrix Medical Communications
2011
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3196303/ https://ncbi.nlm.nih.gov/pubmed/22010053 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|